Naito Yutaka
Department of Molecular Prevention, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.
Department of Molecular Prevention, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Cancer Sci. 2025 Sep;116(9):2347-2361. doi: 10.1111/cas.70133. Epub 2025 Jun 25.
Cancer-associated fibroblasts (CAFs) are the major component of the tumor stroma. They mediate various attributes of tumor cells, such as cell growth, migration, invasion, angiogenesis, metabolic reprogramming, apoptosis, immune regulation, and extracellular matrix reconstitution, all related to cancer progression and treatment resistance. Although many researchers have recognized CAF heterogeneity, recent technological advances have emphasized the functional and phenotypic diversity of CAFs in cancer progression. Why are these CAF subtypes generated within tumor tissues? And how do cancer cells dictate such heterogeneous subtypes of CAFs? This review will highlight the CAF subtypes within the tumor microenvironment and their role in tumor progression. CAF subtype induction by extracellular vesicles (EVs) and their significance, which we reported previously, is also discussed.
癌症相关成纤维细胞(CAFs)是肿瘤基质的主要成分。它们介导肿瘤细胞的多种特性,如细胞生长、迁移、侵袭、血管生成、代谢重编程、凋亡、免疫调节和细胞外基质重构,所有这些都与癌症进展和治疗耐药性相关。尽管许多研究人员已经认识到CAF的异质性,但最近的技术进步强调了CAFs在癌症进展中的功能和表型多样性。为什么这些CAF亚型会在肿瘤组织中产生?癌细胞又是如何决定CAFs的这种异质亚型的?本综述将重点介绍肿瘤微环境中的CAF亚型及其在肿瘤进展中的作用。我们之前报道的细胞外囊泡(EVs)诱导CAF亚型及其意义也将进行讨论。